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Background
Despite the lack of information on the prevalence of HIV
and other STIs among men and trans (transvestites, trans-
sexuals and transgender) sex workers (MSW and TSW
respectively) in Argentina, we found higher prevalences
than expected due to the high vulnerability and degree of
exposure of these populations.
Methods
MSW and TSW >18 years old were recruited during 2006–
2008. After signing an informed consent, a blood sample
was drawn. Anti-HIV, anti-HCV, HBsAg, anti-HBc and
anti-TP were determined. Participants answered a ques-
tionnaire related to sex work.
Results
112 MSW and 170 TSW accepted to participate. Preva-
lences were: HIV: MSW 11.6% (preliminary analysis
showed 4/8 subtype B; 4/8 BF recombinants), TSW:
35.3%(*) (11/23 subtype B, 12/23 BF recombinants);
HBV: 20.0%, TSW: 36.1%(*); HCV: MSW 5.0%, TSW
3.2%, TP: MSW 19.8%, TSW 57.2%(*). *TSW showed sig-
nificantly higher prevalences of HIV, HBV and TP.
Among MSW, 36.2% were infected with at least one path-
ogen while it rose to 80.3% among TSW. The most fre-
quent infections were TP and HBV-TP.
Thirty-eight percent of MSW and 29.8% of TSW had a
steady partner. Irregular use of condom with steady part-
ners was reported in 73.2% of MSW and in 63.9% of TSW.
Most TSW-MSW (73–82%) declared regular use of con-
dom at work.
Use of illegal drugs (any kind) was reported by 28.4% of
MSW and 38% of TSW. Among TSW a significant relation-
ship between illegal drug use and HIV infection was found
(OR = 3.3, 95%CI 1.5–7.3) even though only 4.6% of
them were injecting drug users.
Conclusion
Compared with other high risk populations, MSW and
TSW groups are rarely studied in our country. Considering
the high prevalences observed and the active involvement
of TSW with ATTTA (an NGO dealing with trans people)
this population might be eligible as candidate participants
in case a vaccine trial is planned.
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